Barriers to Healthcare Access and Long-Term Survival After an Acute Coronary Syndrome

被引:0
作者
Nathaniel A. Erskine
Molly E. Waring
David D. McManus
Darleen Lessard
Catarina I. Kiefe
Robert J. Goldberg
机构
[1] University of Massachusetts Medical School,Department of Quantitative Health Sciences
[2] University of Connecticut,Department of Allied Health Sciences, College of Agriculture, Health and Natural Resources
[3] University of Massachusetts Medical School,Division of Cardiovascular Medicine, Department of Medicine
来源
Journal of General Internal Medicine | 2018年 / 33卷
关键词
acute coronary syndrome; healthcare barriers; prospective study;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1543 / 1550
页数:7
相关论文
共 174 条
  • [1] Amsterdam EA(2014)2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 e139-228
  • [2] Wenger NK(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. 127 e362-425
  • [3] Brindis RG(2011)World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation. 124 2458-73
  • [4] Casey DE(2011)Economic burden of illness of acute coronary syndromes: medical and productivity costs BMC Health Serv Res. 11 35-50
  • [5] Ganiats TG(2015)One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel Am J Cardiovasc Drugs. 15 337-9
  • [6] Holmes DR(2010)Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38 Circulation. 121 71-9
  • [7] O’Gara PT(2014)Usual source of care and outcomes following acute myocardial infarction J Gen Intern Med. 29 862-80
  • [8] Kushner FG(2011)Effect of insurance type on adverse cardiac events after percutaneous coronary intervention Am J Cardiol. 107 675-72
  • [9] Ascheim DD(2007)Financial barriers to health care and outcomes after acute myocardial infarction JAMA. 297 1063-62
  • [10] Casey DE(1997)Health insurance coverage and outcome following acute myocardial infarction. A community-wide perspective Arch Intern Med. 157 758-50